7th Annual Update on Liver Disease (RP2310B)
This annual course updates providers on a diverse range of topics including evaluation of liver tests, non-invasive markers of fibrosis, viral hepatitis, autoimmune liver disease, alcohol and metabolic associated fatty liver disease, cirrhosis, portal hypertension, primary liver cancer and liver transplantation. The conference will focus on recent advances, publications and expert opinions. In addition to didactic lectures, case presentations will be included to make the activity interactive and practical.
This course is designed for physicians, physician assistants, nurse practitioners and specialists in Internal Medicine, Gastroenterology and associated disciplines caring for patients with liver disease.
Learning Objectives include:
- Analyze indications and interpretation of viral hepatitis testing and identify those patients who would benefit from antiviral therapy and continued monitoring after treatment.
- Implement appropriate management and identify potential therapies for hepatic steatohepatitis.
- Explain the pathophysiology and manifestations of portal hypertension.
- Apply improved treatment strategies in the clinical management of complications related to portal hypertension.
- Identify the indications for liver transplantation.
- Describe recent advancements in the field and policies changes regarding organ allocation.
- Apply criteria for early detection, diagnosis, and treatment of liver masses including hepatocellular carcinoma and cholangiocarcinoma.
7th Annual Update on Liver Disease
Saturday, October 14, 2023
T. Boone Pickens Auditorium (NG3.112)
UT Southwestern Medical Center, Dallas, TX
AGENDA (Hybrid Learning Format: In-Person and Virtual)
7:00am Registration Opens
7:15am Breakfast and Exhibits
8:00-8:10 Welcome Shannan Tujios
8:10-8:50 Abnormal Liver Tests: Patient Cases Rita Lepe, Indy Bhavsar, Sarah Lieber
8:50-9:10 Non-invasive markers of fibrosis Lafaine Grant
9:10-9:30 Alcohol Associated Liver Disease Thomas Cotter
9:30-10:00 Q&A and Break Morning Panel
10:00-10:40 Viral Hepatitis: Patient Cases Thomas Kerr and Shannan Tujios
10:40-11:00 Primary Care Approach to NAFLD Maddie Kubiliun
11:00-11:20 Emerging Topics in NASH Lisa VanWagner
11:20-11:40 Coagulopathy in Liver Disease Shannan Tujios
11:40-12:00 Talking to Your Patient—Tools that Work Jeremy Louissaint
12:00-1:00 Questions & Answers (Lunch Served) Morning Panel
1:00-1:40 AIH/PBC/PSC: Patients Cases Marlyn Mayo and Mark Pedersen
1:40-2:20 Portal Hypertension: Patients Cases Arjmand Mufti and Lafaine Grant
2:20-2:40 Acute on Chronic Liver Failure Jacqueline O’Leary
2:40-3:00 Break and Exhibits
3:00-3:20 AASLD Guidance for HCC Management Amit Singal
3:20-4:00 Liver Masses/Cancer: Patient Cases Nicole Rich, Madhukar Patel
4:00-4:20 Living Transplant: New Hope Arjmand Mufti
4:20-4:40 Hepatobiliary Surgery Madhukar Patel
4:40-5:00 Questions & Answers Afternoon Panel
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The University of Texas Southwestern Medical Center designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Texas Southwestern Medical Center certifies that non-physicians will receive an attendance certificate stating that they participated in the activity that was designated for 7.5 AMA PRA Category 1 Credit™.
- 7.50 AMA
- 7.50 Attendance